Skip to main content
Fig. 5 | European Journal of Hybrid Imaging

Fig. 5

From: Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer

Fig. 5

Receiver-operator characteristic curve (ROC) analyses of the discrimination efficacy for bone metastatic (BM) versus degenerative change (DC) lesions. Skeletal standardized uptake values (SUVs; SUVmax: maximum of SUV; SUVpeak: peak of SUV; SUVave: average of SUV), alkaline phosphatase (ALP) and prostate specific antigen (PSA) in patient-based (a) and lesion-based (b) analyses have been plotted

Back to article page